Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IMMUNOMEDICS-INC-9671/news/Immunomedics-Announces-Positive-Results-from-Pivotal-Phase-2-TROPHY-U-01-Study-of-Trodelvy-i-31326778/?utm_source=whatsapp&utm_medium=social&utm_campaign=share